June 4, 2024 10:34 AM EDTUpdated June 5, 08:22 AM
News Briefing

Cor­rect­ed: Vilya rais­es $21M in Se­ries A ex­ten­sion; Sh­iono­gi to open re­search cen­ter in San Diego

ENDPOINTS

Plus, news about Im­mutep, Ei­sai and Iterum Ther­a­peu­tics:

Com­pu­ta­tion­al biotech ex­tends Se­ries A: Vilya Ther­a­peu­tics, a start­up based in Seat­tle,

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA vac­cine chief Pe­ter Marks pledges to stay as long as he's wel­come

Am­gen names Stan­ford ge­neti­cist and biotech founder to CSO post

Cal­tech spin­out de­buts with AI-dri­ven 'mir­ror pep­tide' plat­form

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times